The Brigham Board Review and Comprehensiv Update in Hematology and Oncology 2022

Topics/Speakers<br><br>Molecular Genetics of Cancer – Nikhil Wagle, MD<br>Advances in Cancer Drug Development Part I – Chemotherapy and Targeted Agents – Geoffrey I. Shapiro, MD, PhD<br>Advances in Cancer Drug Development Part II – Modulation of the Tumor Microenvironment – Geoffrey I. Shapiro, MD, PhD<br>Infections in Cancer Patients – Lindsey Baden, MD<br>Symptom Management in Patients with Cancer – Andrew J. Lawton, MD<br>Communication: The Key to Excellence in End-of-Life Care – Rachelle E. Bernacki, MD<br>Biology of Hematopoietic Stem Cell Transplantation – Robert J. Soiffer, MD<br>Biology of Acute Leukemia and Myelodysplastic Syndromes – Benjamin L. Ebert, MD, PhD<br>Acute Leukemias – Daniel J. DeAngelo, MD, PhD<br>Myelodysplastic Syndrome – Eric S. Winer, MD<br>Chronic Myelogenous Leukemia – Marlise R. Luskin, MD<br>Myeloproliferative Syndromes – Ann M. Mullally, MD<br>Multiple Myeloma – Kenneth C. Anderson, MD<br>Waldenstrom Macroglobulemia and Amyloidosis – Jorge Castillo, MD<br>Low Grade Lymphomas – Caron A. Jacobson, MD